October 27, 2026

LeMaitre Vascular (LMAT) Stock Analysis: Healthcare Innovator with 26.91% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the medical instruments and supplies industry with its innovative solutions in vascular surgery. This Burlington, Massachusetts-based company, boasting..

NovoCure Limited (NVCR) Stock Analysis: Exploring an 86% Upside Potential in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a pioneering company in the healthcare sector, is capturing the attention of investors with its innovative approach to treating solid tumor cancers...

Recursion Pharmaceuticals (RXRX): Investor Outlook with 92.54% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, continues to garner attention from investors due to its innovative approach to drug discovery..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring the 4% Potential Upside Amid Healthcare Sector Dynamics

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, has captured investor attention with its robust portfolio of medical care facilities across the..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a Promising 10.26% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, is gaining attention among investors for its robust performance and promising outlook. Specializing..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Navigating a 31% Upside Potential in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapies for rare neurological..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 73.5% Upside Potential Amidst Biotech Volatility

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning name in the biotechnology sector, is capturing investor attention with a compelling 73.5% potential upside, as gleaned from current analyst..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Poised for 22% Upside

Progyny, Inc. (NASDAQ: PGNY) is capturing the attention of investors with its innovative approach to healthcare benefits management, specifically in the fertility and family building sector...

Certara, Inc. (CERT) Stock Analysis: Navigating a Healthcare Investment with a 13.59% Downside Risk

Certara, Inc. (CERT), a key player in the healthcare sector, stands as a significant entity within the health information services industry. Headquartered in Radnor, Pennsylvania, this..

GeneDx Holdings Corp. (WGS): Investor Outlook Reveals 52.63% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a pivotal player in the healthcare sector, is drawing significant attention from investors due to its promising potential for growth. Specializing..

Organon & Co. (OGN) Stock Analysis: Is Its Forward P/E of 3.82 a Hidden Gem for Investors?

Organon & Co. (NYSE: OGN), a notable player in the Healthcare sector, operates within the Drug Manufacturers – General industry. Despite its relatively modest market cap..

Viking Therapeutics (VKTX) Stock Analysis: Exploring a 292% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has recently captured the attention of investors with its promising potential upside of 292.62%, as indicated by current analyst ratings. Operating..

Denali Therapeutics Inc. (DNLI) Investor Outlook: 90% Potential Upside Amid Strong Buy Ratings

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing investor attention with a compelling potential upside of 90.25%, as revealed by the latest analyst ratings. This biopharmaceutical company,..

Protagonist Therapeutics (PTGX) Stock Analysis: Biotechnology Innovator with a 27% Upside Potential

Protagonist Therapeutics, Inc. (PTGX) is making waves in the biotechnology sector with a robust pipeline of innovative treatments targeting significant unmet medical needs. Headquartered in Newark,..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 38.74% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology industry, is capturing investor attention with its unique position in the healthcare sector. With a market..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a Potential 54.64% Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, has piqued the interest of investors with its promising drug pipeline and potential for..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Near 48% Upside Potential in Biotech

CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of investors with its promising potential in the biotechnology sector. Specializing in the development of innovative cancer..

Haemonetics Corporation (HAE): Exploring a 4.46% Potential Upside in the Medical Device Sector

Investors with an eye on the healthcare sector should take a closer look at Haemonetics Corporation (NYSE: HAE), a significant player in the medical devices industry...

Perrigo Company plc (PRGO) Stock Analysis: Is This 7.33% Dividend Yield Too Good to Ignore?

Perrigo Company plc (PRGO), headquartered in Dublin, Ireland, stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry...

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 74.72% Potential Upside in the Gene Editing Arena

CRISPR Therapeutics AG (NASDAQ: CRSP), a biotechnology powerhouse based in Switzerland, is making waves in the healthcare sector with its innovative approach to gene editing. Leveraging..

Search

Funds

October 27, 2026

Search

Funds

October 27, 2026

FTSE 100

Funds